Emory University School of Medicine/Winship Cancer Institute Winship Cancer Institute (2) — Atlanta, Georgia

Emory University School of Medicine/Winship Cancer Institute Winship Cancer Institute (2) is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Emory University School of Medicine/Winship Cancer Institute Winship Cancer Institute (2) has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Emory University School of Medicine/Winship Cancer Institute Winship Cancer Institute (2)?

Emory University School of Medicine/Winship Cancer Institute Winship Cancer Institute (2) has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Emory University School of Medicine/Winship Cancer Institute Winship Cancer Institute (2) conducted?

Emory University School of Medicine/Winship Cancer Institute Winship Cancer Institute (2) has 1 clinical trials on record. Their work covers Multiple Myeloma.

Is Emory University School of Medicine/Winship Cancer Institute Winship Cancer Institute (2) accredited by Crixeo Health?

Emory University School of Medicine/Winship Cancer Institute Winship Cancer Institute (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Emory University School of Medicine/Winship Cancer Institute Winship Cancer Institute (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.